Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections
Clinical trial NCT06363370 · RECRUITING
Trial details
- NCT number
- NCT06363370
- Sponsor
- Kexing Biopharm Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-27
- Primary completion
- 2027-06-30
- Enrollment
- 322
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.